The Patent Finder

Azurity Pharmaceuticals, Inc.

Also on record
Records under this name other than the patents Azurity Pharmaceuticals, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 122 patents it holds.

Showing 1 to 8 of 8 · Back to Azurity Pharmaceuticals, Inc.

PatentTitleStatus Expires Confidence
US 12,128,083Lisinopril Formulations
Formerly held
In force
 · Low confidence
In forceLow confidence
US 11,033,498Solid Oral Sulfate Salt Formulations for Cleaning a Colon and Methods of Using Same
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,364,230Amlodipine Formulations
Formerly held
In force
 · High confidence
In forceHigh confidence
US 11,918,684Pharmaceutical Composition of Oral Suspension of Immunosuppressive Agents
Formerly held
In force
 · High confidence
In forceHigh confidence
US 12,042,539Compositions and Kits for Omeprazole Suspension
Formerly held
In force
 · Medium confidence
In forceMedium confidence
US 11,013,702Midodrine Hydrochloride Oral Solution and Uses Thereof
Lapsed on the fee record
Ended May 25, 2025 · High confidence
Lapsed on the fee recordEnded May 25, 2025High confidence
US 12,357,627Pharmaceutical Compositions of Cabozantinib
Term ended
Term ended Oct 19, 2024 · Low confidence
Term endedTerm ended Oct 19, 2024Low confidence
US 6,946,149Salt Solution for Colon Cleansing
Term ended
Term ended Mar 7, 2023 · High confidence
Term endedTerm ended Mar 7, 2023High confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited